As mentioned in the Introduction, the triptan family of drugs relieves acute migraine symptoms while also decreasing CGRP levels; however, triptans increase circulating CGRP and cause allodynia in animals with chronic exposure, and cause MOH in humans when taken too frequently [33]. The gene discussed is CALCA; the disease is migraine disorder.